Literature DB >> 6983404

Modulation of polyclonal B cell differentiation by human leucocyte alpha interferon.

A I Levinson, A Dziarski, J J Hooks.   

Abstract

Although interferon (IFN) profoundly affects immune responses in animals, less is known about its immunoregulatory activity in man. Therefore, peripheral blood mononuclear cells (PBM) from 20 healthy volunteers were incubated with pokeweed mitogen (PWM) in the presence and absence of human leucocyte alpha interferon (IFN alpha). In 18/20 experiments, IFN alpha added at initiation of culture markedly suppressed PWM-induced generation of immunoglobulin secreting cells (IgSC). IFN alpha suppressed proliferative responses in all experiments but the degree of suppression was not correlated with concomitant suppression of IgSC responses. Suppressive activity was resistant to pH 2 treatment but sensitive to treatment with trypsin. Delayed addition of IFN alpha was associated with decreased suppression. Suppression was not due to non-specific cytotoxicity since we observed (1) comparable viabilities in cultures with or without IFN alpha and (2) negligible effect when IFN alpha was added for the final 24 hr of culture. The data confirm previously described effects of IFN on mitogen stimulated PBM and, more importantly, provide convincing evidence that IFN alpha regulates human B cell functions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983404      PMCID: PMC1536707     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Inhibition of the primary in vitro antibody response by interferon preparations.

Authors:  H M Johnson; B G Smith; S Baron
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

Authors:  B R Brodeur; T C Merigan
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

3.  Effects of interferon on antibody synthesis in vitro.

Authors:  R H Gisler; P Lindahl; I Gresser
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

4.  Interferon preparations as modifiers of immune responses.

Authors:  W Braun; H B Levy
Journal:  Proc Soc Exp Biol Med       Date:  1972-12

5.  Suppression of mouse antibody producing spleen cells by various interferon preparations.

Authors:  T J Chester; K Paucker; T C Merigan
Journal:  Nature       Date:  1973-11-09       Impact factor: 49.962

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells.

Authors:  P Lindahl-Magnusson; P Leary; I Gresser
Journal:  Nat New Biol       Date:  1972-05-24

8.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

9.  Modulating effects of interferon preparations on an antibody response in vitro.

Authors:  R J Booth; J M Rastrick; A R Bellamy; J Marbrook
Journal:  Aust J Exp Biol Med Sci       Date:  1976-02

10.  Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.

Authors:  M J Valle; G W Jordan; S Haahr; T C Merigan
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

View more
  3 in total

1.  Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Authors:  H Unoki; A Moriyama; A Tabaru; A Masumoto; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

2.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.

Authors:  Wahid Ali Khan
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.